|
Completed
|
NCT00908037 -
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
|
Phase 2 |
|
Completed
|
NCT00442871 -
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
|
Phase 1 |
|
Completed
|
NCT01098487 -
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
|
Phase 4 |
|
Withdrawn
|
NCT01440361 -
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
|
Phase 2 |
|
Completed
|
NCT01064336 -
Promacta Pregnancy Registry
|
N/A |
|
Completed
|
NCT00424177 -
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
|
Phase 2 |
|
Completed
|
NCT00351468 -
EXTEND (Eltrombopag Extended Dosing Study)
|
Phase 3 |
|
Completed
|
NCT00688272 -
Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag
|
Phase 1 |
|
Completed
|
NCT01072162 -
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
|
Phase 1 |
|
Completed
|
NCT00643929 -
LENS - Long-term Eltrombopag Observational Study
|
N/A |
|
Completed
|
NCT00102739 -
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
|
Phase 2 |
|
Completed
|
NCT00359463 -
Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment
|
Phase 1 |